Tesamorelin is a synthetic peptide that mimics the activity of GHRH
Fatty acid side chain modifications Liraglutide The conjugation of a fatty acid chain to GLP-1 analogs significantly enhances their binding affinity to human serum albumin, thereby generating long-acting peptide formulations with improved pharmacokinetic profiles
At the same time, it also preserves lean muscle mass, which further boosts the metabolism
Biol Pharm Bull 33(8):13241330 Godoy DL, Betts-Obregon BS, Tsin AT (2014) Ginsenoside-Rb1 inhibition of VEGF release-structure and activity relations (SAR) perspective
Elastina hidrolizada: apoya la elasticidad de la piel
The Future While ME/CFS and FM might get lucky with a new drug (such as Cortene), the most likely quick advance in treatment, given the poor funding the field receives, will come from other diseases which share issues